Intimation Under Regulation 30 of SEBI LODR (Regulation) - 2015 Completion and Commencement of Dispatch of Export Order

BSE Limited, Floor 25, P. J. Towers, Dalal Street, Mumbai – 400001 Scrip Code: 543963 Subject: Intimation Under Regulation 30 of SEBI LODR (Regulation)- 2015 Completion and Commencement of Dispatch of Export Order Dear Sir/Madam, Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the stakeholders that the Company has successfully completed the manufacturing of the export purchase order received from Taha Drugs & Chemicals Co. Ltd for the supply of Foliman Tablets and Joemega Capsules. We further wish to inform the said order has been dispatched to Sudan. The Company’s association with Taha Drugs & Chemicals Co. Ltd continues to yield encouraging results, with a steady stream of repeat orders from Sudan, reflecting the strong demand and growing market acceptance of its products. The Company is also receiving exclusive orders from the Sudan market, enabling it to tap into a significant and expanding opportunity in nutraceutical products industry in the region. Every product manufactured by the Company undergoes production under Good Manufacturing Practices (GMP) certified by the FDA, in conjunction with adherence to applicable ISO standards, reinforcing the Company's dedication to consistent quality and manufacturing excellence. Thus, owing to the above-mentioned associations as well as increasing demands from international market, the Company is well equipped to pursue its plan of global expansion. The increased participation in the Sudan market, as well as the opportunity to earn approximately ₹50 crore from this market, provides a significant new opportunity for the Company. Kindly refer to Annexure 1 to further details of the dispatched order, Kindly take the above information on record. Thanking You, FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR MANAGING DIRECTOR DIN: 01456841 Date: 25th August, 2026 Place: Ahmedabad Annexure – 1 Disclosure under Regulation 30 read with schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Particulars Details Name of Customer Taha Drugs & Chemicals Co. Ltd Product Nutraceutical Tablets & Capsules Order Value USD 139200 Manufacturing Status Completed Dispatch Status Completed Value Dispatched till Date USD 139200 Balance Value Pending Dispatch NIL Nature of Order Export Order Destination Country Sudan